Yes, let's make it more difficult for pharmaceutical companies to develop disease curing drugs.
From Diana Carew at the Progressive Policy Institute:
…the number of ‘restrictions’ on drug companies increased by 767, or 40% since 2000. This represents a substantial rise in the overall regulatory burden of pharmaceutical companies, which must allocate resources to ensure regulatory compliance. The word “restriction” refers to command clauses such as “shall” and “must,” as contained in sections of the Code of Federal Regulations related to the FDA.
The full study is here (pdf).
(via Tyler Cowen)
FDA's Janet Woodcock Provides Advice to Patient Advocates
ReplyDeletehttp://www.raredr.com/videos/FDA-Janet-Woodcock-Provides-Advice-Patient-Advocates
so in other words go thru more channels and hopefully we get your message?
don't rattle cans we're working....meanwhile people are dying.